Chemicals

3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-methylprop-2-enoate Cas:1996-88-9

We are 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl 2-methylprop-2-enoate CAS:1996-88-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms：

3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecyl methacrylate

heptadecafluorodecyl methacrylate

3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10-heptadecafluorodecyl methacrylate

1H,1H,2H,2H-Heptadecafluorodecyl methacrylate

1h,1h,2h,2h-perfluorodecyl methacrylate

Perfluorooctyl-ethylene methycrylate

Molecular Formula: C14H9F17O2

Molecular weight：532.19300

Density: 1.596 g/mL at 25 °C(lit.)

Boiling point: 110 °C4 mm Hg(lit.)

Flash point: >230 °F

Refractive index: n20/D 1.343(lit.)

Storage conditions: Keep Cold

Vapor pressure: 0.0199mmHg at 25°C

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News:Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. 3-(3-chloro-phenyl)-1-(4-isopropylamino-6-trichloromethyl-[1,3,5]triazin-2-yl)-1-methyl-urea manufacturer.The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. (E)-1-((1S,5R,7R)-10,10-Dimethyl-3,3-dioxo-3λ6-thia-4-aza-tricyclo[5.2.1.01,5]dec-4-yl)-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-propenone supplier.This further investment in enhanced facilities and continuous staff development provides the increased range of testing services required by the international biopharmaceutical industry. 1-(5-chloro-2-hydroxy-3-nitro-benzoyl)-3-furan-2-yl-2-isonicotinoyl-diaziridine producer.

Product Name
4-Nitrophenyl chloroformate	View Details
Leptomycin B Cas:87081-35-4	View Details
4-Fluoro-2-iodoaniline Cas:61272-76-2	View Details